Subscribe

Find a Job | Employers

Biogen Idec

Biogen Idec is one of the world’s leading biotechnology companies. We discover and develop medicines that change the lives of people living with neurodegenerative diseases, hematologic conditions and autoimmune disorders. Since our founding in 1978, we’ve produced therapies for diseases that affect hundreds of thousands of people around the world.

The world’s oldest independent biotechnology company, Biogen Idec now has the world’s leading portfolio of MS therapies and in 2014, introduced new treatments for hemophilia A and B, which mark the first significant treatment advances for these conditions in almost two decades. We have only started to tap the potential of science to address serious medical conditions. As we look to the future, our success will always be measured by the answer to a simple question: Have we truly made a difference in the lives of the patients we serve?

To that end, we are an ambitious company where courageous innovation is encouraged and expected – not just of our scientists, but of every employee. This is exemplified in every aspect of our business – from our Pharmaceutical Operations and Technology group, who deliver world-class expertise and capabilities in protein engineering and biologics manufacturing, to our customer service representatives, who support our patient communities by offering straightforward information, assistance and patient services. Across the company – in marketing, sales, quality control and human resources – people are empowered to challenge conventional wisdom and propose better ways of doing things.

As a global organization dedicated to improving the well-being of others, our commitments to our patients, our communities and the world at large go beyond simply discovery and delivering important treatment advances. We are committed to being responsible corporate citizens, incorporating our citizenship efforts as a cultural imperative across the organization. We strive to create economic, social and environmental value for our company and our stakeholders with robust programs focused on philanthropy and community engagement, as well as by addressing critical issues like diversity and sustainability.

We plan to continue to focus our resources on the areas where we believe we have expertise to transform patient care. This year and beyond, we intend to:

  • Pursue first-in-class and best-in-class products through a combination of internal research and development and strategic partnerships;
  • Innovate at the intersection of science, medicine and economics to transform the drug development process;
  • Advance a robust pipeline of candidates, targeting exciting new areas of high unmet medical need;
  • Transform the standard of care in hemophilia through the treatment of hemophilia A and B with our long-lasting recombinant proteins for factors VIII and IX; and
  • Expand our global footprint, bringing our therapies to patients that need them around the world, and to work with partners to drive future innovation.

At Biogen Idec, we are proud of our 35 years of contributions to the biotechnology industry, and we look forward to continuing to shape the future of an industry that transforms scientific discovery into advances in patient care. To learn how you can join us in this important mission, visit www.biogenidec.com/careers and explore our current opportunities.